🇺🇸 FDA
Patent

US 11173318

Method of repairing age and disease immune dysfunction and cellular senescence with lymphoid stem cells and then re-applying those for therapeutic use

granted A61KA61K35/12A61K35/16

Quick answer

US patent 11173318 (Method of repairing age and disease immune dysfunction and cellular senescence with lymphoid stem cells and then re-applying those for therapeutic use) held by Advanced Neuroregenerative Therapies, LLC. expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Advanced Neuroregenerative Therapies, LLC.
Grant date
Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K35/12, A61K35/16, A61K35/28, A61K38/18